Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2011-9-2
pubmed:abstractText
The cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) is an important factor determining the functional state of blood-brain barrier (BBB) endothelial cells but little is known on the effect of dynamic [Ca(2+)](i) changes on BBB function. We applied different agonists that trigger [Ca(2+)](i) oscillations and determined the involvement of connexin channels and subsequent effects on endothelial permeability in immortalized and primary brain endothelial cells. The inflammatory peptide bradykinin (BK) triggered [Ca(2+)](i) oscillations and increased endothelial permeability. The latter was prevented by buffering [Ca(2+)](i) with BAPTA, indicating that [Ca(2+)](i) oscillations are crucial in the permeability changes. Bradykinin-triggered [Ca(2+)](i) oscillations were inhibited by interfering with connexin channels, making use of carbenoxolone, Gap27, a peptide blocker of connexin channels, and Cx37/43 knockdown. Gap27 inhibition of the oscillations was rapid (within minutes) and work with connexin hemichannel-permeable dyes indicated hemichannel opening and purinergic signaling in response to stimulation with BK. Moreover, Gap27 inhibited the BK-triggered endothelial permeability increase in in vitro and in vivo experiments. By contrast, [Ca(2+)](i) oscillations provoked by exposure to adenosine 5' triphosphate (ATP) were not affected by carbenoxolone or Gap27 and ATP did not disturb endothelial permeability. We conclude that interfering with endothelial connexin hemichannels is a novel approach to limiting BBB-permeability alterations.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1559-7016
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1942-57
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:21654699-Adenosine Triphosphate, pubmed-meshheading:21654699-Animals, pubmed-meshheading:21654699-Blood-Brain Barrier, pubmed-meshheading:21654699-Bradykinin, pubmed-meshheading:21654699-Calcium, pubmed-meshheading:21654699-Calcium Signaling, pubmed-meshheading:21654699-Carbenoxolone, pubmed-meshheading:21654699-Cattle, pubmed-meshheading:21654699-Cell Line, pubmed-meshheading:21654699-Cells, Cultured, pubmed-meshheading:21654699-Connexins, pubmed-meshheading:21654699-Cytoskeletal Proteins, pubmed-meshheading:21654699-Endothelial Cells, pubmed-meshheading:21654699-Gap Junctions, pubmed-meshheading:21654699-Humans, pubmed-meshheading:21654699-Permeability, pubmed-meshheading:21654699-Rats, pubmed-meshheading:21654699-Rats, Sprague-Dawley, pubmed-meshheading:21654699-Vasodilator Agents
pubmed:year
2011
pubmed:articleTitle
Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability.
pubmed:affiliation
Department of Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural